Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 11 Neoplasm Metastasis 3 Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence Free Survival 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Ovarian Neoplasms 1 Lung Neoplasms 1 Inflammatory Breast Neoplasms 1 Histiocytosis 1 Fallopian Tube Neoplasms 1 Erythema 1 Endometrial Neoplasms 1 Edema 1 Breast Neoplasms 1 Brain Neoplasms 1 Advanced Solid Tumors 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence Free Survival × Panitumumab × 90 days × Clear all

NCT06314997 2026-05-29

Liquid-DRER2

Matteo's Friends

Phase 2 Recruiting

Recurrence Free Survival

Data powered by HemOnc (CC BY 4.0) Colophon ⚡